临床肿瘤学杂志

• 论著 • 上一篇    下一篇

195例鼻咽癌调强放疗的远期疗效及预后分析

徐丽贤1,黄生富2,陈亚楠1,何侠2,张宜勤1,王丽君2   

  1. 1 215600 江苏张家港 张家港市第一人民医院肿瘤科 2 210009 江苏省肿瘤医院放疗科
  • 收稿日期:2015-07-24 修回日期:2015-08-14 出版日期:2015-09-30 发布日期:2015-09-30
  • 通讯作者: 王丽君

Long-term outcome and prognostic factor analysis in 195 cases of nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

XU Lixian, HUANG Shengfu, CHEN Yanan, HE Xia, ZHANG Yiqin, WANG Lijun   

  1. Department of Oncology, Zhangjiagang First People's Hospital, Zhangjiagang 215600, China
  • Received:2015-07-24 Revised:2015-08-14 Online:2015-09-30 Published:2015-09-30
  • Contact: WANG Lijun

摘要: 【摘 要】目的 探讨初治鼻咽癌患者调强放疗(IMRT)的远期疗效并分析预后因素。方法 回顾性分析2005年3月至2010年5月收治的195例(根据鼻咽癌2008分期标准,Ⅰ、Ⅱ、Ⅲ、Ⅳ期分别为9、24、70、92例)初治鼻咽癌患者采用IMRT的临床诊治情况。收集195例患者的一般资料,采用KaplanMeier法进行生存分析,单因素预后分析用Log-rank法,多因素预后分析用Cox回归模型。结果 本组患者的随访率达995%,随访时间满5年者为150例;5年局部控制率、无远处转移生存率、总生存率和无瘤生存率分别为89.2%、81.9%、76.9%和66.2%。经多因素分析,T分期、N分期以及是否联合化疗是影响5年生存率、无远处转移率和无瘤生存率的独立因素;性别是影响5年无远处转移率和无瘤生存率的独立因素。结论 初治鼻咽癌患者采用IMRT能够获得较好的远期疗效和生存质量。除T分期和N分期是影响预后的重要因素外,性别也是预后的重要影响因素,而联合化疗的作用有待进一步的证实。

Abstract: 【Abstract】Objective To investigate the long-term outcome and prognostic factors of nasopharyngeal carcinoma patients(NPC)treated with intensitymodulated radiotherapy(IMRT). Methods The clinical results of 195 newly diagnosed NPC patients treated by IMRT from March 2005 to May 2010 were reviewed. According to the standard of NPC 2008 staging system,there were 9 cases of stageⅠ,24 cases of stage Ⅱ,70 cases of stage Ⅲ and 92 cases of stage Ⅳ. Survival analysis was performed with Kaplan-Meier method. Logrank test was used for evaluating the differences between groups. Multivariate prognostic factors were analyzed by Cox regression model. Results The followup rate was 995%. There were 150 patients followed-up more than 5 years. The 5-year local control rate(LCR),distant metastasis-free survival rate(DMFSR),overall survival rate(OSR)and disease-free survival rate(DESR)were 89.2%,81.9%,76.9% and 66.2%,respectively. Multivariate analysis showed that the independent prognostic factors for 5-year OSR,DMFSR and DFSR were T stage,N stage and the combination with chemotherapy. Gender is an independent prognostic factor for 5-year DMFSR and DFSR. Conclusion NPC treated by IMRT can get good long-term survival with high quality of life. T stage,N stage and gender are important independent prognostic factors for NPC treated by IMRT. The role of combined chemotherapy for locally advanced NPC treated by IMRT needs further investigation.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!